There’s a similar treatment already, CAR-T. The “one size fits all” aspect here is that this receptor mechanism may possibly work with many common solid tumor t

There’s a similar treatment already, CAR-T. The “one size fits all” aspect here is that this receptor mechanism may possibly work with many common solid tumor types (*in mice), whereas CAR-T’s efficacy is limited with solid tumors, but can be dramatic with leukemias and lymphomas. There’s a related therapy for prostate cancer, Provenge (https://en.m.wikipedia.org/wiki/Sipuleucel-T https://en.m.wikipedia.org/wiki/Sipuleucel-T), but it’s merely a life-extending treatment and not the cure that CAR-T can be.